TERRI WADE: Open Payments
NPI 1982637740 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,323 in 64 payments from 29 companies in 2025. Trend: 2023 $1,054 · 2024 $2,462 · 2025 $1,323
Food & beverage: $1,224Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $174 |
| Daiichi Sankyo Inc. | 12 | $143 |
| Janssen Biotech, Inc. | 6 | $118 |
| Celgene Corporation | 4 | $112 |
| AstraZeneca Pharmaceuticals LP | 5 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $71 |
| Genmab U.S., Inc. | 2 | $53 |
| Geron Corporation | 2 | $47 |
| Lilly USA, LLC | 2 | $39 |
| Karyopharm Therapeutics Inc. | 2 | $39 |
Products named: REBLOZYL, Enhertu, Vanflyta, RYBREVANT, JAKAFI, Epkinly, KISQALI, BRUKINSA.
Industry payments across TX — which companies pay providers there.
